In the past five years, immunotherapy has transformed the approach to treating resectable lung cancer in both neoadjuvant and adjuvant settings. During this webinar, experts will explore the continued importance of radiation therapy in managing resectable lung cancer and highlight essential insights that thoracic surgeons need for daily practice.  

Sponsored by AstraZeneca

Moderators: Nathaniel R. Evans III, MD, and John F. Lazar, MD

Presenters: Joshua Reuss, MD, and Maria Werner-Wasik, MD

свернуть